A pilot study to evaluate efficacy and safety of resveratrol for muscular dystrophy.
Not Applicable
- Conditions
- Duchenne muscular dystrophy, Becker muscular dystrophy, Fukuyama congenital muscular dystrophy
- Registration Number
- JPRN-UMIN000014836
- Lead Sponsor
- Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Hypersensitivity to resveratrol. 2) Disqualified for trial by principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method